HomeLiterature Search
Popular searches
A rapid genetic counselling and testing in newly diagnosed breast cancer is ass…

Cortesi(L),Razzaboni(E),Toss(A),De Matteis(E… Ann Oncol 2014-08-11

...BRCA1/2 mutation carriers by up to 95%, but the Italian attitude towards this procedure is reluctant.,This is an observa...

Cinnamaldehyde/chemotherapeutic agents interaction and drug-metabolizing genes …

Yu(Chen),Liu(Shen-Lin),Qi(Ming-Hao),Zou(Xi) Mol Med Rep 2014-08-26

...BRCA1) and topoisomerase 1 (TOPO1), all in HT-29 and LoVo cells, with or without the addition of cinnamaldehyde, was exa...

A novel non-canonical forkhead-associated (FHA) domain-binding interface mediat…

Matthews(Lindsay A),Selvaratnam(Rajeevan),Jo… J Biol Chem 2014-04-10

...BRCA1 C-terminal (BRCT) domains are overrepresented in DNA damage and replication stress response proteins. They functio...

Compensatory functions and interdependency of the DNA-binding domain of BRCA2 w…

Al Abo(Muthana),Dejsuphong(Donniphat),Hirota… Cancer Res 2014-04-15

BRCA1, BRCA2, and PALB2 are key players in cellular tolerance to chemotherapeutic agents, including camptothecin, cispla...

Increased rate of phenocopies in all age groups in BRCA1/BRCA2 mutation kindred…

Evans(D Gareth R),Ingham(Sarah L),Buchan(Iai… Cancer Epidemiol Biomarkers P… 2014-10-02

To establish, if among unaffected noncarrier relatives in a family with an established BRCA1/2 mutation, there is an inc...

Breast and ovarian cancer risks in a large series of clinically ascertained fam…

Brohet(Richard M),Velthuizen(Maria E),Hogerv… J Med Genet 2014-09-08

...BRCA1 and 6% (95% CI 2 to 11%) for BRCA2 mutation carriers. In BRCA1 families, breast cancer relative risk (RR) increase...

Clinical implications of using molecular diagnostics for ovarian cancers.

Kohn(E C),Romano(S),Lee(J-M) Ann Oncol 2014-07-02

...BRCA1 or 2 have been validated as the first new predictive and prognostic biomarker of the high-grade serous ovarian can...

Tumor mutation burden forecasts outcome in ovarian cancer with BRCA1 or BRCA2 m…

Birkbak(Nicolai Juul),Kochupurakkal(Bose),Iz… PLoS One 2014-07-25

...BRCA1 or BRCA2. The significance of these genome-wide mutations is unknown. We hypothesize genome-wide mutation burden m...

CtBP1 overexpression in keratinocytes perturbs skin homeostasis.

Deng(Hui),Li(Fulun),Li(Hong),Deng(Yu),Liu(Ji… J Invest Dermatol 2014-06-17

...Brca1, and E-cadherin, were downregulated in K5.CtBP1 skin. Surprisingly, K5.CtBP1 pups also exhibited a hair loss pheno...

Risk-reducing mastectomy in BRCA1/2 mutation carriers: factors influencing upta…

van Driel(Catheleine M),Eltahir(Yassir),de V… Maturitas 2014-10-14

Strategies in case of high risk of breast cancer in BRCA1/2 mutation carriers are either intensive breast cancer screeni...

Previous 299 300 301 302 303 304 305 306 307 Next Vol. 303 / of 1000

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com